Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Columbia University
Columbia University
National Institutes of Health Clinical Center (CC)
Advanced Accelerator Applications
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AC Camargo Cancer Center
Fudan University
M.D. Anderson Cancer Center
Grupo Espanol de Tumores Neuroendocrinos
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
University Health Network, Toronto
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Peking Union Medical College Hospital
Mayo Clinic
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Excel Diagnostics and Nuclear Oncology Center
Nanjing First Hospital, Nanjing Medical University
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Molecular Insight Pharmaceuticals, Inc.
University of California, San Francisco
National Cancer Institute (NCI)
Seoul National University Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)